BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Sep 27, 2010
 |  BC Week In Review  |  Company News  |  Deals

Ondine Biopharma Corp., Sinuwave Technologies Corp. deal

Ondine divested its majority interest in its Sinuwave Technologies Corp. subsidiary to private investors for $660,000 in cash. Ondine will retain 19.6% interest in Sinuwave. Sinuwave was formed to develop and commercialize photodisinfection...

Read the full 144 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >